header_01a.jpg
 
Akili_Logo_simple.png
 

Imagine what medicine can be.

 

At Akili, we're in the process of building clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games. Our aim is to develop a new type of Digital Medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians. 

Akili was co-founded by PureTech, leading cognitive neuroscientists, and top-tier entertainment software creators. Our operational team is a mix of biomedical scientists and experts in medical device commercialization and interactive design.

science_01.jpg

Scientific Approach

Akili functions on the premise that advances in neuroscience research and consumer-facing technology are enabling a new way to sensitively measure neural function, and intervene in any measured deficits, wherever the patient may be.  Akili's products address both quantitative measurement of and intensive intervention in cognitive functions in a variety of patient populations.

The science behind our first platform, "Project: EVO™", was developed at the University of California, San Francisco by Dr. Adam Gazzaley, Founding Director of the UCSF Neuroscience Imaging Center and Akili's Chief Science Advisor. Dr. Gazzaley's research has led to a patent-pending new software-based method to measure and improve a key system of executive function known as interference processing™. We've deployed these mechanics from the ground up in a consumer videogame interface that runs on mobile phones and tablets, and meets all requirements for rigorous clinical studies. The Project: EVOplatform is currently being tested in a variety of clinical studies in multiple patient populations around the globe, including ADHD, autism, depression, and traumatic brain injury.

products_01.jpg

Cognitive Platform

Our cutting-edge cognitive platform (Project: EVO™) enables multiple clinical products for remote data-capture and intervention, with features designed for extreme patient engagement.  Our proprietary adaptive mechanics allow the software to automatically personalize to the patient's ability level with no clinician input required. We're currently validating each product in a variety of specific patient populations.

Treatment Products

IMPROVE NEURAL FUNCTIONING & COGNITIVE SYMPTOMS

Akili's flagship product line from the Project: EVO™ platform provides a targeted way to potentially improve cognition and disease symptoms through entirely at-home digital interactions.  These treatment products provide Akili’s proprietary interference™ processing therapy with the aim of improving symptoms of inattention, working memory, and executive function.  High-res data collection enables patient compliance tracking and progress analytics for multiple stakeholders.   The leading product, Project: EVO™ ADHD, is currently being evaluated in the STARS-ADHD study.  Akili plans to seek approval from the United States Food and Drug administration for this potential first-in-class treatment if the results of the pivotal study are favorable.   Additional customized treatment products from this platform are being tested in Autism, depression, Alzheimer’s disease, and traumatic brain injury.

Monitor Products

FREQUENT AND SENSITIVE COGNITION measurement

We believe that traditional cognitive tests are barely tolerable by the patient and can lack the sensitivity needed for subtle patient characterization and multiple time point engagement. Measurements over time allow for a plethora of uses, from tracking patients' conditions to understanding the effect of interventions on brain function.  Monitor product allows for short measurements configurable to custom tracking needs (hourly, daily, weekly, etc.).  Each individual assessment utilizes the Project: EVO™ platform’s  proprietary measurement of cognitive control in a format that engages the patient. Our goal is higher quality, ultra-frequent, more sensitive cognitive data for use in clinical decision making and clinical trials.

 

If you want to give your patients a brand new medical experience by running an innovative clinical trial with our software platform, Get in Touch!

iPad_EVO.png
evo-phone.png
partners_01.jpg

Partnerships

Akili works with top universities and premier partners in the healthcare space to bring our products to market.

Pfizer Pharmaceuticals Pfizer Pharmaceuticals (PFE) is currently funding a study to validate the ability of the Project:EVO™ platform to serve as a biomarker or cognitive endpoint for individuals at risk of developing Alzheimer's disease. We believe that this innovative study is the first in which a pharmaceutical company is using a video game to detect a major disease. The study is currently underway.

Pfizer Pharmaceuticals (PFE) is currently funding a study to validate the ability of the Project:EVO™ platform to serve as a biomarker or cognitive endpoint for individuals at risk of developing Alzheimer's disease. We believe that this innovative study is the first in which a pharmaceutical company is using a video game to detect a major disease. The study is currently underway.

logo_shire.png

In 2013, Shire Pharmaceuticals' (SHPG) Strategic Investment group made a direct investment in Akili. Shire is a market-leader in ADHD medications, and has deep experience in ADHD clinical trials. In addition to the monetary investment, Akili and Shire have worked closely together to structure and launch Akili's first clinical study of the Project:EVO™platform in pediatric ADHD. 

  

Merck Ventures joined Akili’s Series B financing in 2016 as an equity investor.  Merck Ventures BV is the strategic, corporate venture capital arm of Merck KGaA, Germany. Merck KGaA is a leading science and technology company for innovative and top-quality high-tech products in healthcare, life sciences and performance materials.  The portfolio includes prescription medications for cancer, multiple sclerosis, and cardiovascular disorders, among many other products.

Amgen Ventures joined Akili’s Series B financing in 2016 as an equity investor.  Amgen Ventures is the strategic ventures capital arm of Amgen and provides emerging innovative companies with financial and other resources to develop pioneering discoveries to treat grievous human illness.  Amgen has a robust product offering and pipeline in oncology, inflammation, and cardiovascular disease.

Autism Speaks, through its not-for-profit investment affiliate DELSIA, entered into a clinical collaboration agreement in early 2015 to support a clinical trial of the Project:EVOplatform in children with autism and co-occurring attention deficits. The trial will be a blinded, randomized, placebo-controlled study that will look to measure cognitive and symptom improvement over 1 month of device play. Recruitment will begin in late 2016.

 

The University of Washington Department of Psychiatry and Behavioral Sciences is conducting a research study to see whether new treatments are effective for depressed, older adults. They are looking for people aged 60 and older who are struggling with mood, depression or low energy. Can a video game that helps older brains work like younger brains be useful in treating depression? Answering this question will help us develop “brain games” that can treat certain types of depression. Participants must be able to participate in MRI scans.
More information can be found at https://clinicaltrials.gov/ct2/show/NCT02229188

 

Additionally, Akili is in the process of licensing and accelerating product development of the very newest published and as-yet-unpublished neuroscience findings that could address major medical indications.

If you have a research program on a patient population with cognitive deficits, or new science that you would like to develop into engaging medical products, please contact Akili at info@akiliinteractive.com

news_01.jpg

Akili News

Akili's novel healthcare approach and the technology behind our first product platform has been covered extensively in recent popular and industry-specific media outlets. Stay tuned for more updates!

people_01.jpg

Our Team

Our team focuses on merging top science with great user experience. We believe patients deserve better, and we're working to make that a reality.

"Why is 'tolerable' the user-experience goal of medicine?  If we make products fun for the patient, we get richer, higher-quality data with a superior experience" - Eddie

"Why is 'tolerable' the user-experience goal of medicine?  If we make products fun for the patient, we get richer, higher-quality data with a superior experience"

- Eddie

Eddie Martucci, PhD

Chief Executive Officer

View bio

"By embracing, rather than fearing, scientific constraints, new and unique game designs can be discovered that would otherwise never have emerged." - Matt O

"By embracing, rather than fearing, scientific constraints, new and unique game designs can be discovered that would otherwise never have emerged."

- Matt O

Matthew Omernick

Chief Creative Officer 

View bio

image_leroux.png

LeRoux Jooste

Chief Commercial Officer

View bio

Kristina Academia

Development Director

View bio

 

David W. Collins

Director of Audio

View bio

 
"In all our efforts (whether scientific, technical, or creative) we always need to try and remember - what is the problem we are trying to solve?" - Frank

"In all our efforts (whether scientific, technical, or creative) we always need to try and remember - what is the problem we are trying to solve?"

- Frank

Frank Hickman

Principal Engineer

View bio

 

Vincent Hennemand

VP of Strategy, Corporate & BD

View bio

 

Marianne Monaghan

Director of Game Product Development

View bio

 

Adam Rogers

Senior Engineer

View bio

"Video games are data-harnessing machines.  Every frame, every movement tells us something about the user they didn't even know about themselves" - Bower

"Video games are data-harnessing machines.  Every frame, every movement tells us something about the user they didn't even know about themselves"

- Bower

Jeffery Bower, PhD

Director of Data Science

View bio

 

Sandra D. Brown, PhD, Esq

VP of IP & Legal Affairs

View bio

 

Emre Gulturk

Medical Device QA Manager

View bio

 

Kathryn Jenkins

Clinical Project Manager

View bio

 

Dan Mycka

Senior Artist

View bio

 

Brendon Smith

Senior Engineer

View bio

 

Kristin Vaselacopoulos

Office, Style & Events Manager

View bio

"Data science and neuroscience are both progressing at an unparalleled pace, leaving a vast new landscape of opportunities for non-invasively measuring and driving changes deep within the brain." -Titi

"Data science and neuroscience are both progressing at an unparalleled pace, leaving a vast new landscape of opportunities for non-invasively measuring and driving changes deep within the brain."

-Titi

Titi Ala'ilima

Director of Data Engineering

View bio

 
image_laurac.png

Laura Chavez-Noriega, PhD

Sr Director of Medical & Scientific Communications

View bio

 

Mae-ellen Gavin

VP of Healthcare Solutions

View bio

 
"Running clinical studies is no different with a game than with a traditional device: attention to detail, planning, and the right outcomes make all the difference." - Scott

"Running clinical studies is no different with a game than with a traditional device: attention to detail, planning, and the right outcomes make all the difference."

- Scott

Scott C. Kellogg

VP of Operations

View bio

 
"It’s rewarding to blaze a trail that can make a difference.  The design, code, and all of us have traveled creative roads that we wouldn’t have otherwise traveled" - Piper

"It’s rewarding to blaze a trail that can make a difference.  The design, code, and all of us have traveled creative roads that we wouldn’t have otherwise traveled"

- Piper

Adam Piper

Lead Engineer / Designer

View bio

 
  "Video games from the start have been pushing the boundaries of Art, Science and Technology.  Medical game development is one of the most exciting and beneficial intersections of all three." -Jeff 

 

"Video games from the start have been pushing the boundaries of Art, Science and Technology.  Medical game development is one of the most exciting and beneficial intersections of all three."

-Jeff 

Jeff Steinmetz

Principal Architect

View bio

 

Jimmy Zhou

Data Analyst

View bio

Mark Bergo

Senior Artist

View bio

 
Laura Rounded.png

Dan Goddard

Operations Manager

View bio

 
JJ Pic round.png

Jason Johnson

Senior Research & Development Engineer

View bio

 
"Medical games will be embraced by the patients because they are engaging and by physicians because they provide unprecedented and unmatched assessments and therapies." -Ashley

"Medical games will be embraced by the patients because they are engaging and by physicians because they provide unprecedented and unmatched assessments and therapies."

-Ashley

Ashley Mateus, PhD

Director of Market Strategy

View bio

 

Brevin Pretorius

QA Games Manager

View bio

 

Jason Trees

Game Optimization Analyst

View bio

 

 

Our Board

 

 
Adam Gazzaley, MD PhD Board Member view bio

Adam Gazzaley, MD PhD

Board Member

view bio

Ben Shapiro, MD Board Member view bio

Ben Shapiro, MD

Board Member

view bio

Eric Elenko, PhD Board Member view bio

Eric Elenko, PhD

Board Member

view bio

Daphne Zohar Board Member view bio

Daphne Zohar

Board Member

view bio

 
 
Joi Ito Board Member view bio

Joi Ito

Board Member

view bio

Jamie Gates Board Member view bio

Jamie Gates

Board Member

view bio

John Spinale Board Member view bio

John Spinale

Board Member

view bio

 
 
 

Our Advisors

 
Geraldine Dawson, PhD view bio

Geraldine Dawson, PhD

view bio

Amit Etkin, MD, PhD view bio

Amit Etkin, MD, PhD

view bio

Steve Faraone, PhD view bio

Steve Faraone, PhD

view bio

Carmen Bozic, MD view bio

Carmen Bozic, MD

view bio

Maurizio Fava, PhD view bio

Maurizio Fava, PhD

view bio

Richard Davidson, PhD view bio

Richard Davidson, PhD

view bio

Robert T. Schultz, PhD view bio

Robert T. Schultz, PhD

view bio

Scott Kollins, PhD view bio

Scott Kollins, PhD

view bio

 
 
Glenn Entis view bio

Glenn Entis

view bio

Daphne Bavelier, PhD Co-Founding Advisor view bio

Daphne Bavelier, PhD

Co-Founding Advisor

view bio

Philip Rosedale Co-Founding Advisor view bio

Philip Rosedale

Co-Founding Advisor

view bio

 
contact_01.jpg

Get In Touch!

Whether you are the parent of a child who might benefit from Akili products and services, a health professional who would like more information about Akili, or a business professional who would like to partner with Akili...please send us a message using the form below. An Akili executive or team member will get back to you shortly.

We are always looking for exceptional people to join our team!

 

Connect with us online!